UBS ASSET MANAGEMENT AMERICAS INC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 09:51 am Sale |
2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
UBS ASSET MANAGEMENT AMERICAS INC | 1,935,957 1.210% |
-9,245,494 (-82.69%) |
Filing |